Glenmark partners event on child malnutrition in India

Concerned over infant child mortality rate in India, FICCI, Aditya Birla CSR Centre for Excellence and Glenmark Pharmaceuticals join hands to combat child malnutrition. Organize first of its kind knowledge initiative with experts from all fields


The Federation of Indian Chambers of Commerce and Industry (FICCI) alongwith Aditya Birla CSR Centre for Excellence and Glenmark Pharmaceuticals Ltd in a first of its kind initiative, on August 23, 2013, organized a conference titled 'Child Malnutrition: Sharing of Best Practices' at New Delhi.

Aimed at understand different solutions to address issues of child malnutrition and bring out a knowledge paper on best practices in combating the malaise, the conference brought leaders from government, corporate, NGOs and relief agencies on the same platform and share their wealth of experience.

Speaking at the inaugural session, Dr K K Upadhyay Head CSR at FICCI said "given that every third malnourished child lives in India and that zero to five age bracket constitutes the most vulnerable zone, corporate houses should incorporate child health in the core agenda of Corporate Social Responsibility".
Upadhyay also said what is surprising is the fact that slums of Mumbai house higher number of children malnourished as compared to even the remotest areas in the country.

Dr Sila Deb, Deputy Commissioner (Child Health) Ministry of Health and Family Welfare, Government of India said "the foremost weapon to fight malnourishment among children should be to convince mothers to breastfeed children from the very first hour of birth.

Deb also said that severely malnourished children are 8 to 12 times more likely to die as compared to normal malnourished children and there is a clear need to build capacity of healthcare workers or ASHA to fight child morbidity and mortality.

Previous 1 Next

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

National Health Policy

Is National Health Policy 2017 helpful for patients?

Send this article by email